Studies have shown that cytokines such as interleukin-6, interleukin-8, and tumor necrosis factor-alpha, which are the mediators of the inflammatory response in COVID-19, can trigger a procoagulant state, resulting in changes in the menstrual pattern and in the amount of bleeding following infection [13, 16]. The gene discussed is IL6; the disease is COVID-19.